← NDC auxiliary source history
Current NDC auxiliary source rows
Every current FDA unfinished, excluded, package, product, and compounder source row. Empty or malformed identifiers and report-scoped rows remain addressable by their exact source record and row.
Counts come from the five current base tables. The atomic loader verifies that every base source row has exactly one status projection before publication; directory pages use that verified projection and retain exact base-row detail links.
| Exact source record | Source row | Dataset | Record source | Scope | Status | Status meaning | Product NDC | Package NDC | Product / substance | Application | Reporting period | Normalization | Notes | Source date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
outsourcing:2019-1:1351 | 1351 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2019-2:1351 | 1351 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2505 | 72627-2505-3 | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2019-2 | valid | 0 | 2026-10-21 | |
outsourcing:2020-1:1351 | 1351 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-2:1351 | 1351 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2021-1:1351 | 1351 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71139-0012 | 71139-0012-1 | Oxytocin | 2021-1 | valid | 0 | 2026-10-21 | |
outsourcing:2021-2:1351 | 1351 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5275 | 26436-5275-1 | Papaverine Hydrochloride; Alprostadil; Phentolamine Mesylate | 2021-2 | valid | 0 | 2026-10-21 | |
outsourcing:2022-1:1351 | 1351 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2430 | 72627-2430-1 | Sodium Bicarbonate | 2022-1 | valid | 0 | 2026-10-21 | |
outsourcing:2022-2:1351 | 1351 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9130 | 71266-9130-1 | Ropivacaine Hydrochloride | 2022-2 | valid | 0 | 2026-10-21 | |
outsourcing:2023-1:1351 | 1351 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Prednisolone Sodium Phosphate; Moxifloxacin Hydrochloride | 2023-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2023-2:1351 | 1351 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Prednisolone Sodium Phosphate; Moxifloxacin Hydrochloride; Ketorolac Tromethamine | 2023-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2024-1:1351 | 1351 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-984 | 69374-984-10 | Sodium Bicarbonate; Lidocaine Hydrochloride; Potassium Chloride | 2024-1 | valid | 0 | 2026-10-21 | |
outsourcing:2024-2:1351 | 1351 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-126 | 71449-126-15 | Succinylcholine Chloride | 2024-2 | valid | 0 | 2026-10-21 | |
outsourcing:2025-1:1351 | 1351 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-116 | 73177-116-03 | Succinylcholine Chloride | 2025-1 | valid | 0 | 2026-10-21 | |
outsourcing:2025-2:1351 | 1351 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-1025 | 73271-1025-1 | Testosterone | 2025-2 | valid | 0 | 2026-10-21 | |
outsourcing:2026-1:1351 | 1351 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-6020 | 26436-6020-3 | Testosterone | 2026-1 | valid | 0 | 2026-10-21 | |
compounder:1352 | 1352 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0104 | 72196-0104-1 | Maintenance 4 to 1 Low K (36 mEq) Low Tromethamine 1000ml Bag | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1352 | 1352 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2019-2:1352 | 1352 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2506 | 72627-2506-3 | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2019-2 | valid | 0 | 2026-10-21 | |
outsourcing:2020-1:1352 | 1352 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-2:1352 | 1352 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 62295-3322 | 62295-3322-7 | Phenylephrine Hydrochloride | 2020-2 | valid | 0 | 2026-10-21 | |
outsourcing:2021-1:1352 | 1352 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2021-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2021-2:1352 | 1352 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5176 | 26436-5176-2 | Papaverine Hydrochloride; Alprostadil; Phentolamine Mesylate | 2021-2 | valid | 0 | 2026-10-21 | |
outsourcing:2022-1:1352 | 1352 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70324-326 | 70324-326-01 | Sodium Bicarbonate | 2022-1 | valid | 0 | 2026-10-21 | |
outsourcing:2022-2:1352 | 1352 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-109 | 73177-109-14 | Ropivacaine Hydrochloride | 2022-2 | valid | 0 | 2026-10-21 | |
outsourcing:2023-1:1352 | 1352 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81375-300 | 81375-300-08 | Prednisolone Sodium Phosphate; Moxifloxacin Hydrochloride; Bromfenac Sodium | 2023-1 | valid | 0 | 2026-10-21 | |
outsourcing:2023-2:1352 | 1352 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Prednisolone Sodium Phosphate; Moxifloxacin Hydrochloride; Ketorolac Tromethamine | 2023-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2024-1:1352 | 1352 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0042 | 81483-0042-0 | Sodium Chloride | 2024-1 | valid | 0 | 2026-10-21 | |
outsourcing:2024-2:1352 | 1352 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-919 | 69374-919-10 | Succinylcholine Chloride | 2024-2 | valid | 0 | 2026-10-21 | |
outsourcing:2025-1:1352 | 1352 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-116 | 73177-116-02 | Succinylcholine Chloride | 2025-1 | valid | 0 | 2026-10-21 | |
outsourcing:2025-2:1352 | 1352 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0040 | 73271-0040-1 | Testosterone | 2025-2 | valid | 0 | 2026-10-21 | |
outsourcing:2026-1:1352 | 1352 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-1025 | 73271-1025-1 | Testosterone | 2026-1 | valid | 0 | 2026-10-21 | |
compounder:1353 | 1353 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-077 | 73198-077-30 | L-Lysine 100 mg/mL | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1353 | 1353 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2019-2:1353 | 1353 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2019-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-1:1353 | 1353 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-2:1353 | 1353 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2021-1:1353 | 1353 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6037 | 72196-6037-1 | Oxytocin | 2021-1 | valid | 0 | 2026-10-21 | |
outsourcing:2021-2:1353 | 1353 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5466 | 26436-5466-5 | Papaverine Hydrochloride; Alprostadil; Phentolamine Mesylate | 2021-2 | valid | 0 | 2026-10-21 | |
outsourcing:2022-1:1353 | 1353 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-914 | 69374-914-50 | Sodium Bicarbonate | 2022-1 | valid | 0 | 2026-10-21 | |
outsourcing:2022-2:1353 | 1353 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-109 | 73177-109-13 | Ropivacaine Hydrochloride | 2022-2 | valid | 0 | 2026-10-21 | |
outsourcing:2023-1:1353 | 1353 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81375-300 | 81375-300-05 | Prednisolone Sodium Phosphate; Moxifloxacin Hydrochloride; Bromfenac Sodium | 2023-1 | valid | 0 | 2026-10-21 | |
outsourcing:2023-2:1353 | 1353 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Prednisolone Sodium Phosphate; Moxifloxacin Hydrochloride; Ketorolac Tromethamine | 2023-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2024-1:1353 | 1353 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0032 | 81483-0032-0 | Sodium Chloride | 2024-1 | valid | 0 | 2026-10-21 | |
outsourcing:2024-2:1353 | 1353 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Succinylcholine Chloride | 2024-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2025-1:1353 | 1353 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71170-020 | 71170-020-05 | Succinylcholine Chloride | 2025-1 | valid | 0 | 2026-10-21 | |
outsourcing:2025-2:1353 | 1353 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0055 | 73271-0055-1 | Testosterone | 2025-2 | valid | 0 | 2026-10-21 | |
outsourcing:2026-1:1353 | 1353 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-006 | 70713-006-01 | Testosterone | 2026-1 | valid | 0 | 2026-10-21 | |
compounder:1354 | 1354 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-6286 | 71266-6286-3 | Lidocaine and Epinephrine and Tetracaine | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1354 | 1354 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 60652-0600 | 60652-0600-1 | Hydromorphone Hydrochloride | 2019-1 | valid | 0 | 2026-10-21 | |
outsourcing:2019-2:1354 | 1354 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2019-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-1:1354 | 1354 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-2:1354 | 1354 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2021-1:1354 | 1354 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6038 | 72196-6038-1 | Oxytocin | 2021-1 | valid | 0 | 2026-10-21 | |
outsourcing:2021-2:1354 | 1354 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5265 | 26436-5265-5 | Papaverine Hydrochloride; Alprostadil; Phentolamine Mesylate | 2021-2 | valid | 0 | 2026-10-21 | |
outsourcing:2022-1:1354 | 1354 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-214 | 69374-214-50 | Sodium Bicarbonate | 2022-1 | valid | 0 | 2026-10-21 | |
outsourcing:2022-2:1354 | 1354 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-221 | 70092-221-38 | Ropivacaine Hydrochloride | 2022-2 | valid | 0 | 2026-10-21 | |
outsourcing:2023-1:1354 | 1354 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Prednisolone Sodium Phosphate; Moxifloxacin Hydrochloride; Ketorolac Tromethamine | 2023-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2023-2:1354 | 1354 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83343-005 | 83343-005-30 | Procaine | 2023-2 | valid | 0 | 2026-10-21 | |
outsourcing:2024-1:1354 | 1354 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 65302-509 | 65302-509-30 | Sodium Chloride | 2024-1 | valid | 0 | 2026-10-21 | |
outsourcing:2024-2:1354 | 1354 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71170-020 | 71170-020-05 | Succinylcholine Chloride | 2024-2 | valid | 0 | 2026-10-21 | |
outsourcing:2025-1:1354 | 1354 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 82396-173 | 82396-173-10 | Succinylcholine Chloride | 2025-1 | valid | 0 | 2026-10-21 | |
outsourcing:2025-2:1354 | 1354 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-002 | 70713-002-01 | Testosterone | 2025-2 | valid | 0 | 2026-10-21 | |
outsourcing:2026-1:1354 | 1354 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-0121 | 70168-0121-1 | Testosterone | 2026-1 | valid | 0 | 2026-10-21 | |
compounder:1355 | 1355 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72907-2115 | 72907-2115-3 | Methylprednisolone Acetate | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1355 | 1355 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2019-2:1355 | 1355 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2019-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-1:1355 | 1355 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-2:1355 | 1355 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2021-1:1355 | 1355 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6039 | 72196-6039-1 | Oxytocin | 2021-1 | valid | 0 | 2026-10-21 | |
outsourcing:2021-2:1355 | 1355 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5097 | 26436-5097-5 | Papaverine Hydrochloride; Alprostadil; Phentolamine Mesylate | 2021-2 | valid | 0 | 2026-10-21 | |
outsourcing:2022-1:1355 | 1355 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Sodium Bicarbonate | 2022-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2022-2:1355 | 1355 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ropivacaine Hydrochloride | 2022-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2023-1:1355 | 1355 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5044 | 26436-5044-3 | Procaine Hydrochloride | 2023-1 | valid | 0 | 2026-10-21 | |
outsourcing:2023-2:1355 | 1355 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5044 | 26436-5044-3 | Procaine Hydrochloride | 2023-2 | valid | 0 | 2026-10-21 | |
outsourcing:2024-1:1355 | 1355 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 82396-618 | 82396-618-10 | Sodium Chloride | 2024-1 | valid | 0 | 2026-10-21 | |
outsourcing:2024-2:1355 | 1355 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Succinylcholine Chloride | 2024-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2025-1:1355 | 1355 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Succinylcholine Chloride | 2025-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2025-2:1355 | 1355 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-033 | 70713-033-01 | Testosterone | 2025-2 | valid | 0 | 2026-10-21 | |
outsourcing:2026-1:1355 | 1355 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-0011 | 70168-0011-1 | Testosterone | 2026-1 | valid | 0 | 2026-10-21 | |
compounder:1356 | 1356 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-131 | 71449-131-11 | Dexmedetomidine Hydrochloride | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1356 | 1356 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2019-2:1356 | 1356 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2019-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-1:1356 | 1356 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-2:1356 | 1356 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-6008 | 71286-6008-1 | Phenylephrine Hydrochloride | 2020-2 | valid | 0 | 2026-10-21 | |
outsourcing:2021-1:1356 | 1356 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6042 | 72196-6042-1 | Oxytocin | 2021-1 | valid | 0 | 2026-10-21 | |
outsourcing:2021-2:1356 | 1356 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5137 | 26436-5137-5 | Papaverine Hydrochloride; Alprostadil; Phentolamine Mesylate | 2021-2 | valid | 0 | 2026-10-21 | |
outsourcing:2022-1:1356 | 1356 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-984 | 69374-984-10 | Sodium Bicarbonate; Lidocaine Hydrochloride; Potassium Chloride | 2022-1 | valid | 0 | 2026-10-21 | |
outsourcing:2022-2:1356 | 1356 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ropivacaine Hydrochloride | 2022-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2023-1:1356 | 1356 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5248 | 26436-5248-1 | Progesterone | 2023-1 | valid | 0 | 2026-10-21 | |
outsourcing:2023-2:1356 | 1356 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 67157-005 | 67157-005-30 | Procaine; Sodium Metabisulfite | 2023-2 | valid | 0 | 2026-10-21 | |
outsourcing:2024-1:1356 | 1356 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0204 | 71285-0204-1 | Sodium Chloride; Magnesium Sulfate Heptahydrate; Potassium Chloride; Sodium Bicarbonate; Calcium Chloride | 2024-1 | valid | 0 | 2026-10-21 | |
outsourcing:2024-2:1356 | 1356 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Succinylcholine Chloride | 2024-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2025-1:1356 | 1356 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Succinylcholine Chloride | 2025-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2025-2:1356 | 1356 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-055 | 70713-055-01 | Testosterone | 2025-2 | valid | 0 | 2026-10-21 | |
outsourcing:2026-1:1356 | 1356 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-0040 | 70168-0040-1 | Testosterone | 2026-1 | valid | 0 | 2026-10-21 | |
compounder:1357 | 1357 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-7025 | 71285-7025-1 | Phenylephrine 20mg added to NS | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1357 | 1357 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2019-2:1357 | 1357 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 2019-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-1:1357 | 1357 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-2:1357 | 1357 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-001 | 71449-001-11 | Phenylephrine Hydrochloride | 2020-2 | valid | 0 | 2026-10-21 | |
outsourcing:2021-1:1357 | 1357 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6043 | 72196-6043-1 | Oxytocin | 2021-1 | valid | 0 | 2026-10-21 | |
outsourcing:2021-2:1357 | 1357 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2500 | 72627-2500-3 | Papaverine Hydrochloride; Phentolamine Mesylate | 2021-2 | valid | 0 | 2026-10-21 | |
outsourcing:2022-1:1357 | 1357 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-8035 | 71285-8035-1 | Sodium Chloride | 2022-1 | valid | 0 | 2026-10-21 | |
outsourcing:2022-2:1357 | 1357 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-657 | 70092-657-76 | Ropivacaine Hydrochloride | 2022-2 | valid | 0 | 2026-10-21 | |
outsourcing:2023-1:1357 | 1357 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5152 | 26436-5152-1 | Progesterone | 2023-1 | valid | 0 | 2026-10-21 | |
outsourcing:2023-2:1357 | 1357 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-3020 | 70168-3020-1 | Progesterone | 2023-2 | valid | 0 | 2026-10-21 | |
outsourcing:2024-1:1357 | 1357 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0203 | 71285-0203-1 | Sodium Chloride; Magnesium Sulfate Heptahydrate; Potassium Chloride; Sodium Bicarbonate; Calcium Chloride | 2024-1 | valid | 0 | 2026-10-21 | |
outsourcing:2024-2:1357 | 1357 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72055-013 | 72055-013-01 | Succinylcholine Chloride | 2024-2 | valid | 0 | 2026-10-21 | |
outsourcing:2025-1:1357 | 1357 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72055-001 | 72055-001-01 | Succinylcholine Chloride | 2025-1 | valid | 0 | 2026-10-21 | |
outsourcing:2025-2:1357 | 1357 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-006 | 70713-006-01 | Testosterone | 2025-2 | valid | 0 | 2026-10-21 | |
outsourcing:2026-1:1357 | 1357 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-002 | 70713-002-01 | Testosterone | 2026-1 | valid | 0 | 2026-10-21 | |
compounder:1358 | 1358 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5037 | 26436-5037-1 | Trimix 10/30/1 | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1358 | 1358 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2019-2:1358 | 1358 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 2019-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-1:1358 | 1358 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-2:1358 | 1358 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-001 | 71449-001-15 | Phenylephrine Hydrochloride | 2020-2 | valid | 0 | 2026-10-21 | |
outsourcing:2021-1:1358 | 1358 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6039 | 71285-6039-1 | Oxytocin | 2021-1 | valid | 0 | 2026-10-21 | |
outsourcing:2021-2:1358 | 1358 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2501 | 72627-2501-3 | Papaverine Hydrochloride; Phentolamine Mesylate | 2021-2 | valid | 0 | 2026-10-21 | |
outsourcing:2022-1:1358 | 1358 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-8035 | 71285-8035-2 | Sodium Chloride | 2022-1 | valid | 0 | 2026-10-21 | |
outsourcing:2022-2:1358 | 1358 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ropivacaine Hydrochloride | 2022-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2023-1:1358 | 1358 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-0324 | 26436-0324-1 | Progesterone | 2023-1 | valid | 0 | 2026-10-21 | |
outsourcing:2023-2:1358 | 1358 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-036 | 70713-036-01 | Progesterone | 2023-2 | valid | 0 | 2026-10-21 | |
outsourcing:2024-1:1358 | 1358 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0212 | 71285-0212-1 | Sodium Chloride; Sodium Gluconate; Sodium Acetate; Potassium Chloride; Magnesium Chloride; Lidocaine Hydrochloride; Sodium Bicarbonate | 2024-1 | valid | 0 | 2026-10-21 | |
outsourcing:2024-2:1358 | 1358 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72055-001 | 72055-001-01 | Succinylcholine Chloride | 2024-2 | valid | 0 | 2026-10-21 | |
outsourcing:2025-1:1358 | 1358 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72055-013 | 72055-013-01 | Succinylcholine Chloride | 2025-1 | valid | 0 | 2026-10-21 | |
outsourcing:2025-2:1358 | 1358 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 79559-1050 | 79559-1050-1 | Testosterone | 2025-2 | valid | 0 | 2026-10-21 | |
outsourcing:2026-1:1358 | 1358 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-033 | 70713-033-01 | Testosterone | 2026-1 | valid | 0 | 2026-10-21 | |
compounder:1359 | 1359 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 84582-4104 | 84582-4104-3 | SEMAGLUTIDE | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1359 | 1359 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2019-2:1359 | 1359 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 2019-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-1:1359 | 1359 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-2:1359 | 1359 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2021-1:1359 | 1359 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6042 | 71285-6042-1 | Oxytocin | 2021-1 | valid | 0 | 2026-10-21 | |
outsourcing:2021-2:1359 | 1359 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2505 | 72627-2505-3 | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2021-2 | valid | 0 | 2026-10-21 | |
outsourcing:2022-1:1359 | 1359 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-8035 | 72196-8035-1 | Sodium Chloride | 2022-1 | valid | 0 | 2026-10-21 | |
outsourcing:2022-2:1359 | 1359 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-333 | 70092-333-75 | Ropivacaine Hydrochloride | 2022-2 | valid | 0 | 2026-10-21 | |
outsourcing:2023-1:1359 | 1359 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5062 | 26436-5062-1 | Progesterone | 2023-1 | valid | 0 | 2026-10-21 | |
outsourcing:2023-2:1359 | 1359 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5152 | 26436-5152-1 | Progesterone | 2023-2 | valid | 0 | 2026-10-21 | |
outsourcing:2024-1:1359 | 1359 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Sodium Tetradecyl Sulfate | 2024-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2024-2:1359 | 1359 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-1351 | 61141-1351-1 | Succinylcholine Chloride | 2024-2 | valid | 0 | 2026-10-21 | |
outsourcing:2025-1:1359 | 1359 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2001 | 71266-2001-1 | Succinylcholine Chloride | 2025-1 | valid | 0 | 2026-10-21 | |
outsourcing:2025-2:1359 | 1359 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69761-252 | 69761-252-01 | Testosterone | 2025-2 | valid | 0 | 2026-10-21 | |
outsourcing:2026-1:1359 | 1359 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-0100 | 70168-0100-1 | Testosterone | 2026-1 | valid | 0 | 2026-10-21 | |
compounder:1360 | 1360 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-113 | 73702-113-15 | Neostigmine Methylsulfate | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1360 | 1360 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2019-2:1360 | 1360 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 2019-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-1:1360 | 1360 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-2:1360 | 1360 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2021-1:1360 | 1360 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6031 | 71285-6031-1 | Oxytocin | 2021-1 | valid | 0 | 2026-10-21 | |
outsourcing:2021-2:1360 | 1360 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2506 | 72627-2506-3 | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2021-2 | valid | 0 | 2026-10-21 | |
outsourcing:2022-1:1360 | 1360 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0033 | 81483-0033-0 | Sodium Chloride | 2022-1 | valid | 0 | 2026-10-21 | |
outsourcing:2022-2:1360 | 1360 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-335 | 70092-335-76 | Ropivacaine Hydrochloride | 2022-2 | valid | 0 | 2026-10-21 | |
outsourcing:2023-1:1360 | 1360 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-1124 | 26436-1124-1 | Progesterone | 2023-1 | valid | 0 | 2026-10-21 | |
outsourcing:2023-2:1360 | 1360 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5248 | 26436-5248-1 | Progesterone | 2023-2 | valid | 0 | 2026-10-21 | |
outsourcing:2024-1:1360 | 1360 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1333 | 72934-1333-2 | Spironolactone; Benzoyl Peroxide; Clindamycin Phosphate; Niacinamide; Tretinoin | 2024-1 | valid | 0 | 2026-10-21 | |
outsourcing:2024-2:1360 | 1360 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 65302-504 | 65302-504-05 | Succinylcholine Chloride | 2024-2 | valid | 0 | 2026-10-21 | |
outsourcing:2025-1:1360 | 1360 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2001 | 71266-2001-2 | Succinylcholine Chloride | 2025-1 | valid | 0 | 2026-10-21 | |
outsourcing:2025-2:1360 | 1360 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69761-372 | 69761-372-01 | Testosterone | 2025-2 | valid | 0 | 2026-10-21 | |
outsourcing:2026-1:1360 | 1360 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-0041 | 70168-0041-1 | Testosterone | 2026-1 | valid | 0 | 2026-10-21 | |
compounder:1361 | 1361 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-035 | 71506-035-56 | Acyclovir Sodium | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1361 | 1361 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2019-2:1361 | 1361 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 2019-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-1:1361 | 1361 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-2:1361 | 1361 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-956 | 69374-956-10 | Phenylephrine Hydrochloride | 2020-2 | valid | 0 | 2026-10-21 | |
outsourcing:2021-1:1361 | 1361 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6032 | 71285-6032-1 | Oxytocin | 2021-1 | valid | 0 | 2026-10-21 | |
outsourcing:2021-2:1361 | 1361 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2503 | 72627-2503-3 | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 2021-2 | valid | 0 | 2026-10-21 | |
outsourcing:2022-1:1361 | 1361 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0032 | 81483-0032-0 | Sodium Chloride | 2022-1 | valid | 0 | 2026-10-21 | |
outsourcing:2022-2:1361 | 1361 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-079 | 71449-079-51 | Ropivacaine Hydrochloride | 2022-2 | valid | 0 | 2026-10-21 | |
outsourcing:2023-1:1361 | 1361 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-3020 | 70168-3020-1 | Progesterone | 2023-1 | valid | 0 | 2026-10-21 | |
outsourcing:2023-2:1361 | 1361 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-3030 | 70168-3030-1 | Progesterone | 2023-2 | valid | 0 | 2026-10-21 | |
outsourcing:2024-1:1361 | 1361 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1334 | 72934-1334-2 | Spironolactone; Benzoyl Peroxide; Clindamycin Phosphate; Niacinamide; Tretinoin | 2024-1 | valid | 0 | 2026-10-21 | |
outsourcing:2024-2:1361 | 1361 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 65302-504 | 65302-504-10 | Succinylcholine Chloride | 2024-2 | valid | 0 | 2026-10-21 | |
outsourcing:2025-1:1361 | 1361 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9684 | 71266-9684-5 | Succinylcholine Chloride | 2025-1 | valid | 0 | 2026-10-21 | |
outsourcing:2025-2:1361 | 1361 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69761-122 | 69761-122-01 | Testosterone | 2025-2 | valid | 0 | 2026-10-21 | |
outsourcing:2026-1:1361 | 1361 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-6016 | 26436-6016-1 | Testosterone | 2026-1 | valid | 0 | 2026-10-21 | |
compounder:1362 | 1362 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5005 | 71266-5005-1 | Fentanyl | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1362 | 1362 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2019-2:1362 | 1362 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 2019-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-1:1362 | 1362 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-2:1362 | 1362 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2021-1:1362 | 1362 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6036 | 71285-6036-1 | Oxytocin | 2021-1 | valid | 0 | 2026-10-21 | |
outsourcing:2021-2:1362 | 1362 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 2021-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2022-1:1362 | 1362 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-003 | 71506-003-10 | Sodium Chloride | 2022-1 | valid | 0 | 2026-10-21 | |
outsourcing:2022-2:1362 | 1362 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-431 | 70092-431-76 | Ropivacaine Hydrochloride | 2022-2 | valid | 0 | 2026-10-21 | |
outsourcing:2023-1:1362 | 1362 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-026 | 70713-026-01 | Progesterone | 2023-1 | valid | 0 | 2026-10-21 | |
outsourcing:2023-2:1362 | 1362 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-0324 | 26436-0324-1 | Progesterone | 2023-2 | valid | 0 | 2026-10-21 | |
outsourcing:2024-1:1362 | 1362 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2325 | 72934-2325-2 | Spironolactone; Dapsone; Niacinamide | 2024-1 | valid | 0 | 2026-10-21 | |
outsourcing:2024-2:1362 | 1362 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72055-015 | 72055-015-01 | Sugammadex | 2024-2 | valid | 0 | 2026-10-21 | |
outsourcing:2025-1:1362 | 1362 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Succinylcholine Chloride | 2025-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2025-2:1362 | 1362 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69761-102 | 69761-102-01 | Testosterone | 2025-2 | valid | 0 | 2026-10-21 | |
outsourcing:2026-1:1362 | 1362 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-055 | 70713-055-01 | Testosterone | 2026-1 | valid | 0 | 2026-10-21 | |
compounder:1363 | 1363 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8120 | 71266-8120-1 | Epinephrine | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1363 | 1363 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-300 | 70004-300-18 | Hydromorphone Hydrochloride | 2019-1 | valid | 0 | 2026-10-21 | |
outsourcing:2019-2:1363 | 1363 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 2019-2 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-1:1363 | 1363 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-21 | |||
outsourcing:2020-2:1363 | 1363 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-816 | 70004-816-12 | Phenylephrine Hydrochloride | 2020-2 | valid | 0 | 2026-10-21 | |
outsourcing:2021-1:1363 | 1363 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6037 | 71285-6037-1 | Oxytocin | 2021-1 | valid | 0 | 2026-10-21 | |
outsourcing:2021-2:1363 | 1363 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2504 | 72627-2504-3 | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil; Atropine Sulfate | 2021-2 | valid | 0 | 2026-10-21 | |
outsourcing:2022-1:1363 | 1363 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-128 | 73177-128-05 | Sodium Chloride | 2022-1 | valid | 0 | 2026-10-21 | |
outsourcing:2022-2:1363 | 1363 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-070 | 71449-070-25 | Ropivacaine Hydrochloride | 2022-2 | valid | 0 | 2026-10-21 |